As of 2024-07-27, the Fair Value of Rigel Pharmaceuticals Inc (RIGL) is -5.64 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.75 USD, the upside of Rigel Pharmaceuticals Inc is -152.44%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -66.90 | -29.70 | -17.90 | -58.60 | -25.09 | -39.64 |
| YoY growth | 5.11% | 55.61% | 39.73% | -227.37% | 57.18% | -13.95% |
| Market Cap (mil) | 188.77 |
| P/E | |
| Forward P/E |
| EPS | -1.13 |
| Avg earnings growth rate | -13.95% |
| TTM earnings | -19.80 |